nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—HTR2A—coronary artery disease	0.142	1	CbGaD
Trifluoperazine—HTR1A—Penbutolol—coronary artery disease	0.0601	0.161	CbGbCtD
Trifluoperazine—ABCB1—Ticagrelor—coronary artery disease	0.0328	0.088	CbGbCtD
Trifluoperazine—CYP1A2—Gemfibrozil—coronary artery disease	0.0268	0.0717	CbGbCtD
Trifluoperazine—CYP1A2—Clopidogrel—coronary artery disease	0.0232	0.0622	CbGbCtD
Trifluoperazine—ABCB1—Clopidogrel—coronary artery disease	0.0203	0.0544	CbGbCtD
Trifluoperazine—ABCB1—Perindopril—coronary artery disease	0.0203	0.0544	CbGbCtD
Trifluoperazine—ABCB1—Pitavastatin—coronary artery disease	0.0177	0.0475	CbGbCtD
Trifluoperazine—ABCB1—Telmisartan—coronary artery disease	0.0177	0.0475	CbGbCtD
Trifluoperazine—ABCB1—Enalapril—coronary artery disease	0.0168	0.045	CbGbCtD
Trifluoperazine—ABCB1—Lisinopril—coronary artery disease	0.0168	0.045	CbGbCtD
Trifluoperazine—ABCB1—Timolol—coronary artery disease	0.0143	0.0383	CbGbCtD
Trifluoperazine—ABCB1—Ezetimibe—coronary artery disease	0.0131	0.035	CbGbCtD
Trifluoperazine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0127	0.0341	CbGbCtD
Trifluoperazine—ABCB1—Captopril—coronary artery disease	0.0126	0.0337	CbGbCtD
Trifluoperazine—ABCB1—Simvastatin—coronary artery disease	0.0122	0.0326	CbGbCtD
Trifluoperazine—ABCB1—Pravastatin—coronary artery disease	0.0119	0.0319	CbGbCtD
Trifluoperazine—ABCB1—Lovastatin—coronary artery disease	0.0119	0.0319	CbGbCtD
Trifluoperazine—CYP1A2—Losartan—coronary artery disease	0.0113	0.0304	CbGbCtD
Trifluoperazine—ABCB1—Atorvastatin—coronary artery disease	0.0108	0.029	CbGbCtD
Trifluoperazine—ABCB1—Losartan—coronary artery disease	0.00991	0.0265	CbGbCtD
Trifluoperazine—CALM1—sympathetic nervous system—coronary artery disease	0.00362	0.0524	CbGeAlD
Trifluoperazine—HTR2A—arteriole—coronary artery disease	0.00346	0.0501	CbGeAlD
Trifluoperazine—S100A4—cardiac ventricle—coronary artery disease	0.0027	0.0391	CbGeAlD
Trifluoperazine—S100A4—myocardium—coronary artery disease	0.00254	0.0368	CbGeAlD
Trifluoperazine—CALM1—autonomic nervous system—coronary artery disease	0.00243	0.0352	CbGeAlD
Trifluoperazine—TNNC1—cardiac ventricle—coronary artery disease	0.00227	0.0329	CbGeAlD
Trifluoperazine—HTR2A—pulmonary artery—coronary artery disease	0.00227	0.0328	CbGeAlD
Trifluoperazine—EBPL—heart—coronary artery disease	0.00225	0.0325	CbGeAlD
Trifluoperazine—HTR2A—sympathetic nervous system—coronary artery disease	0.00221	0.0319	CbGeAlD
Trifluoperazine—TNNC1—myocardium—coronary artery disease	0.00214	0.0309	CbGeAlD
Trifluoperazine—HTR2A—vagus nerve—coronary artery disease	0.00214	0.0309	CbGeAlD
Trifluoperazine—HTR2A—vein—coronary artery disease	0.00206	0.0299	CbGeAlD
Trifluoperazine—S100A4—heart—coronary artery disease	0.00177	0.0257	CbGeAlD
Trifluoperazine—S100A4—cardiovascular system—coronary artery disease	0.00167	0.0242	CbGeAlD
Trifluoperazine—S100A4—cardiac atrium—coronary artery disease	0.00152	0.0219	CbGeAlD
Trifluoperazine—TNNC1—heart—coronary artery disease	0.00149	0.0216	CbGeAlD
Trifluoperazine—HTR2A—autonomic nervous system—coronary artery disease	0.00148	0.0214	CbGeAlD
Trifluoperazine—TNNC1—cardiovascular system—coronary artery disease	0.00141	0.0204	CbGeAlD
Trifluoperazine—CALM2—artery—coronary artery disease	0.00139	0.0201	CbGeAlD
Trifluoperazine—CALM1—artery—coronary artery disease	0.00138	0.02	CbGeAlD
Trifluoperazine—S100A4—blood—coronary artery disease	0.00132	0.0191	CbGeAlD
Trifluoperazine—TNNC1—cardiac atrium—coronary artery disease	0.00128	0.0185	CbGeAlD
Trifluoperazine—CALM2—endothelium—coronary artery disease	0.00117	0.0169	CbGeAlD
Trifluoperazine—CALM1—endothelium—coronary artery disease	0.00117	0.0169	CbGeAlD
Trifluoperazine—UGT1A4—blood—coronary artery disease	0.00116	0.0168	CbGeAlD
Trifluoperazine—TNNC1—blood—coronary artery disease	0.00111	0.0161	CbGeAlD
Trifluoperazine—CALM3—cardiac ventricle—coronary artery disease	0.000991	0.0143	CbGeAlD
Trifluoperazine—CALM3—myocardium—coronary artery disease	0.000932	0.0135	CbGeAlD
Trifluoperazine—SIGMAR1—cardiac ventricle—coronary artery disease	0.000885	0.0128	CbGeAlD
Trifluoperazine—HTR2A—artery—coronary artery disease	0.000841	0.0122	CbGeAlD
Trifluoperazine—SIGMAR1—myocardium—coronary artery disease	0.000833	0.012	CbGeAlD
Trifluoperazine—CALM2—cardiac ventricle—coronary artery disease	0.000778	0.0112	CbGeAlD
Trifluoperazine—CALM1—cardiac ventricle—coronary artery disease	0.000774	0.0112	CbGeAlD
Trifluoperazine—CALM2—myocardium—coronary artery disease	0.000732	0.0106	CbGeAlD
Trifluoperazine—CALM1—myocardium—coronary artery disease	0.000728	0.0105	CbGeAlD
Trifluoperazine—HTR2A—endothelium—coronary artery disease	0.00071	0.0103	CbGeAlD
Trifluoperazine—CALM3—heart—coronary artery disease	0.00065	0.0094	CbGeAlD
Trifluoperazine—CHRM2—heart—coronary artery disease	0.000641	0.00926	CbGeAlD
Trifluoperazine—CHRM2—cardiovascular system—coronary artery disease	0.000604	0.00874	CbGeAlD
Trifluoperazine—SIGMAR1—heart—coronary artery disease	0.000581	0.00841	CbGeAlD
Trifluoperazine—CALM3—cardiac atrium—coronary artery disease	0.000556	0.00804	CbGeAlD
Trifluoperazine—CALM2—heart—coronary artery disease	0.000511	0.00739	CbGeAlD
Trifluoperazine—CALM1—heart—coronary artery disease	0.000508	0.00735	CbGeAlD
Trifluoperazine—SIGMAR1—cardiac atrium—coronary artery disease	0.000497	0.00719	CbGeAlD
Trifluoperazine—HTR1A—cardiovascular system—coronary artery disease	0.00049	0.00709	CbGeAlD
Trifluoperazine—CALM3—blood—coronary artery disease	0.000485	0.00702	CbGeAlD
Trifluoperazine—CALM2—cardiovascular system—coronary artery disease	0.000482	0.00697	CbGeAlD
Trifluoperazine—CALM1—cardiovascular system—coronary artery disease	0.00048	0.00694	CbGeAlD
Trifluoperazine—ADRA1A—heart—coronary artery disease	0.000479	0.00693	CbGeAlD
Trifluoperazine—ADRA1A—cardiovascular system—coronary artery disease	0.000452	0.00654	CbGeAlD
Trifluoperazine—CALM2—cardiac atrium—coronary artery disease	0.000437	0.00632	CbGeAlD
Trifluoperazine—CALM1—cardiac atrium—coronary artery disease	0.000435	0.00629	CbGeAlD
Trifluoperazine—SIGMAR1—blood—coronary artery disease	0.000434	0.00627	CbGeAlD
Trifluoperazine—CALM2—blood—coronary artery disease	0.000381	0.00551	CbGeAlD
Trifluoperazine—CALM1—blood—coronary artery disease	0.000379	0.00549	CbGeAlD
Trifluoperazine—Clomipramine—HRH2—coronary artery disease	0.000366	0.0873	CrCbGaD
Trifluoperazine—ADRA1A—blood—coronary artery disease	0.000357	0.00517	CbGeAlD
Trifluoperazine—Loxapine—HRH2—coronary artery disease	0.000318	0.0758	CrCbGaD
Trifluoperazine—HTR2A—heart—coronary artery disease	0.00031	0.00448	CbGeAlD
Trifluoperazine—CYP1A2—blood—coronary artery disease	0.000296	0.00427	CbGeAlD
Trifluoperazine—HTR2A—cardiovascular system—coronary artery disease	0.000292	0.00423	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—coronary artery disease	0.000237	0.0565	CrCbGaD
Trifluoperazine—HTR2A—blood—coronary artery disease	0.000231	0.00334	CbGeAlD
Trifluoperazine—ABCB1—heart—coronary artery disease	0.000203	0.00293	CbGeAlD
Trifluoperazine—ABCB1—cardiovascular system—coronary artery disease	0.000192	0.00277	CbGeAlD
Trifluoperazine—Flupentixol—HTR2A—coronary artery disease	0.000163	0.039	CrCbGaD
Trifluoperazine—Clomipramine—GSTP1—coronary artery disease	0.000152	0.0362	CrCbGaD
Trifluoperazine—ABCB1—blood—coronary artery disease	0.000151	0.00219	CbGeAlD
Trifluoperazine—Constipation—Trandolapril—coronary artery disease	0.000138	0.000674	CcSEcCtD
Trifluoperazine—Urticaria—Valsartan—coronary artery disease	0.000138	0.000673	CcSEcCtD
Trifluoperazine—Decreased appetite—Telmisartan—coronary artery disease	0.000138	0.000673	CcSEcCtD
Trifluoperazine—Nausea—Rosuvastatin—coronary artery disease	0.000138	0.000673	CcSEcCtD
Trifluoperazine—Constipation—Enalapril—coronary artery disease	0.000137	0.000671	CcSEcCtD
Trifluoperazine—Dyspnoea—Captopril—coronary artery disease	0.000137	0.000671	CcSEcCtD
Trifluoperazine—Urticaria—Olmesartan—coronary artery disease	0.000137	0.00067	CcSEcCtD
Trifluoperazine—Somnolence—Captopril—coronary artery disease	0.000137	0.000669	CcSEcCtD
Trifluoperazine—Fatigue—Telmisartan—coronary artery disease	0.000137	0.000667	CcSEcCtD
Trifluoperazine—Body temperature increased—Olmesartan—coronary artery disease	0.000136	0.000667	CcSEcCtD
Trifluoperazine—Pruritus—Ezetimibe—coronary artery disease	0.000136	0.000666	CcSEcCtD
Trifluoperazine—Hypotension—Furosemide—coronary artery disease	0.000136	0.000664	CcSEcCtD
Trifluoperazine—Vision blurred—Timolol—coronary artery disease	0.000136	0.000664	CcSEcCtD
Trifluoperazine—Constipation—Telmisartan—coronary artery disease	0.000135	0.000662	CcSEcCtD
Trifluoperazine—Agitation—Ramipril—coronary artery disease	0.000135	0.000662	CcSEcCtD
Trifluoperazine—Hypersensitivity—Simvastatin—coronary artery disease	0.000135	0.000661	CcSEcCtD
Trifluoperazine—Insomnia—Perindopril—coronary artery disease	0.000135	0.000661	CcSEcCtD
Trifluoperazine—Asthenia—Eplerenone—coronary artery disease	0.000135	0.000661	CcSEcCtD
Trifluoperazine—Angioedema—Ramipril—coronary artery disease	0.000135	0.000658	CcSEcCtD
Trifluoperazine—Urticaria—Niacin—coronary artery disease	0.000134	0.000655	CcSEcCtD
Trifluoperazine—Decreased appetite—Captopril—coronary artery disease	0.000134	0.000654	CcSEcCtD
Trifluoperazine—Anorexia—Losartan—coronary artery disease	0.000134	0.000653	CcSEcCtD
Trifluoperazine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000134	0.000653	CcSEcCtD
Trifluoperazine—Erythema—Lisinopril—coronary artery disease	0.000134	0.000653	CcSEcCtD
Trifluoperazine—Pruritus—Eplerenone—coronary artery disease	0.000133	0.000652	CcSEcCtD
Trifluoperazine—Dyspnoea—Perindopril—coronary artery disease	0.000133	0.000652	CcSEcCtD
Trifluoperazine—Body temperature increased—Niacin—coronary artery disease	0.000133	0.000651	CcSEcCtD
Trifluoperazine—Dizziness—Fenofibrate—coronary artery disease	0.000133	0.00065	CcSEcCtD
Trifluoperazine—Somnolence—Perindopril—coronary artery disease	0.000133	0.00065	CcSEcCtD
Trifluoperazine—Fatigue—Captopril—coronary artery disease	0.000133	0.000649	CcSEcCtD
Trifluoperazine—Leukopenia—Ramipril—coronary artery disease	0.000132	0.000645	CcSEcCtD
Trifluoperazine—Urticaria—Pravastatin—coronary artery disease	0.000132	0.000645	CcSEcCtD
Trifluoperazine—Asthenia—Simvastatin—coronary artery disease	0.000132	0.000644	CcSEcCtD
Trifluoperazine—Constipation—Captopril—coronary artery disease	0.000132	0.000644	CcSEcCtD
Trifluoperazine—Angioedema—Timolol—coronary artery disease	0.000132	0.000643	CcSEcCtD
Trifluoperazine—Body temperature increased—Pravastatin—coronary artery disease	0.000131	0.000641	CcSEcCtD
Trifluoperazine—Hypotension—Losartan—coronary artery disease	0.000131	0.000641	CcSEcCtD
Trifluoperazine—Dizziness—Clopidogrel—coronary artery disease	0.000131	0.000639	CcSEcCtD
Trifluoperazine—Decreased appetite—Perindopril—coronary artery disease	0.00013	0.000635	CcSEcCtD
Trifluoperazine—Pruritus—Simvastatin—coronary artery disease	0.00013	0.000635	CcSEcCtD
Trifluoperazine—Dizziness—Lovastatin—coronary artery disease	0.00013	0.000635	CcSEcCtD
Trifluoperazine—Nervousness—Lisinopril—coronary artery disease	0.00013	0.000634	CcSEcCtD
Trifluoperazine—Somnolence—Furosemide—coronary artery disease	0.000129	0.000632	CcSEcCtD
Trifluoperazine—Fatigue—Perindopril—coronary artery disease	0.000129	0.00063	CcSEcCtD
Trifluoperazine—Cough—Ramipril—coronary artery disease	0.000129	0.000628	CcSEcCtD
Trifluoperazine—Muscle spasms—Lisinopril—coronary artery disease	0.000129	0.000628	CcSEcCtD
Trifluoperazine—Urticaria—Trandolapril—coronary artery disease	0.000128	0.000626	CcSEcCtD
Trifluoperazine—Cyamemazine—HTR2A—coronary artery disease	0.000128	0.0306	CrCbGaD
Trifluoperazine—Constipation—Perindopril—coronary artery disease	0.000128	0.000625	CcSEcCtD
Trifluoperazine—Hypersensitivity—Valsartan—coronary artery disease	0.000128	0.000624	CcSEcCtD
Trifluoperazine—Convulsion—Ramipril—coronary artery disease	0.000128	0.000624	CcSEcCtD
Trifluoperazine—Urticaria—Enalapril—coronary artery disease	0.000128	0.000623	CcSEcCtD
Trifluoperazine—Body temperature increased—Trandolapril—coronary artery disease	0.000127	0.000623	CcSEcCtD
Trifluoperazine—Dizziness—Ezetimibe—coronary artery disease	0.000127	0.000622	CcSEcCtD
Trifluoperazine—Body temperature increased—Enalapril—coronary artery disease	0.000127	0.00062	CcSEcCtD
Trifluoperazine—Insomnia—Losartan—coronary artery disease	0.000127	0.00062	CcSEcCtD
Trifluoperazine—Rash—Fenofibrate—coronary artery disease	0.000127	0.00062	CcSEcCtD
Trifluoperazine—Dermatitis—Fenofibrate—coronary artery disease	0.000127	0.000619	CcSEcCtD
Trifluoperazine—Decreased appetite—Furosemide—coronary artery disease	0.000126	0.000618	CcSEcCtD
Trifluoperazine—Headache—Fenofibrate—coronary artery disease	0.000126	0.000616	CcSEcCtD
Trifluoperazine—Vision blurred—Lisinopril—coronary artery disease	0.000126	0.000616	CcSEcCtD
Trifluoperazine—Urticaria—Telmisartan—coronary artery disease	0.000126	0.000615	CcSEcCtD
Trifluoperazine—Cough—Timolol—coronary artery disease	0.000126	0.000614	CcSEcCtD
Trifluoperazine—Fatigue—Furosemide—coronary artery disease	0.000125	0.000613	CcSEcCtD
Trifluoperazine—Tremor—Lisinopril—coronary artery disease	0.000125	0.000612	CcSEcCtD
Trifluoperazine—Body temperature increased—Telmisartan—coronary artery disease	0.000125	0.000612	CcSEcCtD
Trifluoperazine—Dyspnoea—Losartan—coronary artery disease	0.000125	0.000611	CcSEcCtD
Trifluoperazine—Somnolence—Losartan—coronary artery disease	0.000125	0.000609	CcSEcCtD
Trifluoperazine—Dizziness—Eplerenone—coronary artery disease	0.000125	0.000609	CcSEcCtD
Trifluoperazine—Rash—Clopidogrel—coronary artery disease	0.000125	0.000609	CcSEcCtD
Trifluoperazine—Dermatitis—Clopidogrel—coronary artery disease	0.000125	0.000609	CcSEcCtD
Trifluoperazine—Asthenia—Valsartan—coronary artery disease	0.000124	0.000608	CcSEcCtD
Trifluoperazine—Constipation—Furosemide—coronary artery disease	0.000124	0.000608	CcSEcCtD
Trifluoperazine—Hypersensitivity—Niacin—coronary artery disease	0.000124	0.000607	CcSEcCtD
Trifluoperazine—Asthenia—Olmesartan—coronary artery disease	0.000124	0.000605	CcSEcCtD
Trifluoperazine—Headache—Clopidogrel—coronary artery disease	0.000124	0.000605	CcSEcCtD
Trifluoperazine—Rash—Lovastatin—coronary artery disease	0.000124	0.000605	CcSEcCtD
Trifluoperazine—Dermatitis—Lovastatin—coronary artery disease	0.000124	0.000604	CcSEcCtD
Trifluoperazine—Headache—Lovastatin—coronary artery disease	0.000123	0.000601	CcSEcCtD
Trifluoperazine—Pruritus—Valsartan—coronary artery disease	0.000123	0.0006	CcSEcCtD
Trifluoperazine—Dry mouth—Ramipril—coronary artery disease	0.000123	0.0006	CcSEcCtD
Trifluoperazine—Hypersensitivity—Pravastatin—coronary artery disease	0.000122	0.000598	CcSEcCtD
Trifluoperazine—Angioedema—Lisinopril—coronary artery disease	0.000122	0.000597	CcSEcCtD
Trifluoperazine—Pruritus—Olmesartan—coronary artery disease	0.000122	0.000597	CcSEcCtD
Trifluoperazine—Decreased appetite—Losartan—coronary artery disease	0.000122	0.000596	CcSEcCtD
Trifluoperazine—Body temperature increased—Captopril—coronary artery disease	0.000122	0.000595	CcSEcCtD
Trifluoperazine—Dizziness—Simvastatin—coronary artery disease	0.000121	0.000594	CcSEcCtD
Trifluoperazine—Rash—Ezetimibe—coronary artery disease	0.000121	0.000593	CcSEcCtD
Trifluoperazine—Dermatitis—Ezetimibe—coronary artery disease	0.000121	0.000593	CcSEcCtD
Trifluoperazine—Asthenia—Niacin—coronary artery disease	0.000121	0.000591	CcSEcCtD
Trifluoperazine—Fatigue—Losartan—coronary artery disease	0.000121	0.000591	CcSEcCtD
Trifluoperazine—Headache—Ezetimibe—coronary artery disease	0.000121	0.00059	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Ramipril—coronary artery disease	0.00012	0.000588	CcSEcCtD
Trifluoperazine—Dry mouth—Timolol—coronary artery disease	0.00012	0.000586	CcSEcCtD
Trifluoperazine—Constipation—Losartan—coronary artery disease	0.00012	0.000586	CcSEcCtD
Trifluoperazine—Leukopenia—Lisinopril—coronary artery disease	0.00012	0.000585	CcSEcCtD
Trifluoperazine—Nausea—Fenofibrate—coronary artery disease	0.000119	0.000584	CcSEcCtD
Trifluoperazine—Pruritus—Niacin—coronary artery disease	0.000119	0.000583	CcSEcCtD
Trifluoperazine—Asthenia—Pravastatin—coronary artery disease	0.000119	0.000582	CcSEcCtD
Trifluoperazine—Rash—Eplerenone—coronary artery disease	0.000119	0.000581	CcSEcCtD
Trifluoperazine—Urticaria—Perindopril—coronary artery disease	0.000119	0.000581	CcSEcCtD
Trifluoperazine—Hypersensitivity—Trandolapril—coronary artery disease	0.000119	0.000581	CcSEcCtD
Trifluoperazine—Dermatitis—Eplerenone—coronary artery disease	0.000119	0.00058	CcSEcCtD
Trifluoperazine—Hypersensitivity—Enalapril—coronary artery disease	0.000118	0.000578	CcSEcCtD
Trifluoperazine—Body temperature increased—Perindopril—coronary artery disease	0.000118	0.000578	CcSEcCtD
Trifluoperazine—Headache—Eplerenone—coronary artery disease	0.000118	0.000577	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Timolol—coronary artery disease	0.000118	0.000575	CcSEcCtD
Trifluoperazine—Pruritus—Pravastatin—coronary artery disease	0.000117	0.000574	CcSEcCtD
Trifluoperazine—Nausea—Clopidogrel—coronary artery disease	0.000117	0.000574	CcSEcCtD
Trifluoperazine—Thioridazine—HTR7—coronary artery disease	0.000117	0.028	CrCbGaD
Trifluoperazine—Skin disorder—Ramipril—coronary artery disease	0.000117	0.000571	CcSEcCtD
Trifluoperazine—Hypersensitivity—Telmisartan—coronary artery disease	0.000117	0.00057	CcSEcCtD
Trifluoperazine—Cough—Lisinopril—coronary artery disease	0.000117	0.00057	CcSEcCtD
Trifluoperazine—Nausea—Lovastatin—coronary artery disease	0.000117	0.00057	CcSEcCtD
Trifluoperazine—Rash—Simvastatin—coronary artery disease	0.000116	0.000566	CcSEcCtD
Trifluoperazine—Dermatitis—Simvastatin—coronary artery disease	0.000116	0.000565	CcSEcCtD
Trifluoperazine—Asthenia—Trandolapril—coronary artery disease	0.000116	0.000565	CcSEcCtD
Trifluoperazine—Urticaria—Furosemide—coronary artery disease	0.000115	0.000564	CcSEcCtD
Trifluoperazine—Asthenia—Enalapril—coronary artery disease	0.000115	0.000563	CcSEcCtD
Trifluoperazine—Headache—Simvastatin—coronary artery disease	0.000115	0.000562	CcSEcCtD
Trifluoperazine—Body temperature increased—Furosemide—coronary artery disease	0.000115	0.000562	CcSEcCtD
Trifluoperazine—Dizziness—Valsartan—coronary artery disease	0.000115	0.000561	CcSEcCtD
Trifluoperazine—Anorexia—Ramipril—coronary artery disease	0.000115	0.00056	CcSEcCtD
Trifluoperazine—Nausea—Ezetimibe—coronary artery disease	0.000114	0.000559	CcSEcCtD
Trifluoperazine—Skin disorder—Timolol—coronary artery disease	0.000114	0.000558	CcSEcCtD
Trifluoperazine—Dizziness—Olmesartan—coronary artery disease	0.000114	0.000558	CcSEcCtD
Trifluoperazine—Pruritus—Trandolapril—coronary artery disease	0.000114	0.000558	CcSEcCtD
Trifluoperazine—Asthenia—Telmisartan—coronary artery disease	0.000114	0.000555	CcSEcCtD
Trifluoperazine—Pruritus—Enalapril—coronary artery disease	0.000114	0.000555	CcSEcCtD
Trifluoperazine—Hypotension—Ramipril—coronary artery disease	0.000112	0.000549	CcSEcCtD
Trifluoperazine—Anorexia—Timolol—coronary artery disease	0.000112	0.000548	CcSEcCtD
Trifluoperazine—Pruritus—Telmisartan—coronary artery disease	0.000112	0.000548	CcSEcCtD
Trifluoperazine—Nausea—Eplerenone—coronary artery disease	0.000112	0.000547	CcSEcCtD
Trifluoperazine—Dizziness—Niacin—coronary artery disease	0.000112	0.000545	CcSEcCtD
Trifluoperazine—Urticaria—Losartan—coronary artery disease	0.000111	0.000545	CcSEcCtD
Trifluoperazine—Dry mouth—Lisinopril—coronary artery disease	0.000111	0.000544	CcSEcCtD
Trifluoperazine—Body temperature increased—Losartan—coronary artery disease	0.000111	0.000542	CcSEcCtD
Trifluoperazine—Asthenia—Captopril—coronary artery disease	0.000111	0.00054	CcSEcCtD
Trifluoperazine—Hypotension—Timolol—coronary artery disease	0.00011	0.000537	CcSEcCtD
Trifluoperazine—Dizziness—Pravastatin—coronary artery disease	0.00011	0.000537	CcSEcCtD
Trifluoperazine—Rash—Valsartan—coronary artery disease	0.000109	0.000534	CcSEcCtD
Trifluoperazine—Dermatitis—Valsartan—coronary artery disease	0.000109	0.000534	CcSEcCtD
Trifluoperazine—Nausea—Simvastatin—coronary artery disease	0.000109	0.000533	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000109	0.000533	CcSEcCtD
Trifluoperazine—Pruritus—Captopril—coronary artery disease	0.000109	0.000533	CcSEcCtD
Trifluoperazine—Rash—Olmesartan—coronary artery disease	0.000109	0.000532	CcSEcCtD
Trifluoperazine—Insomnia—Ramipril—coronary artery disease	0.000109	0.000532	CcSEcCtD
Trifluoperazine—Dermatitis—Olmesartan—coronary artery disease	0.000109	0.000531	CcSEcCtD
Trifluoperazine—Headache—Valsartan—coronary artery disease	0.000109	0.000531	CcSEcCtD
Trifluoperazine—Headache—Olmesartan—coronary artery disease	0.000108	0.000528	CcSEcCtD
Trifluoperazine—Loxapine—HTR7—coronary artery disease	0.000108	0.0258	CrCbGaD
Trifluoperazine—Perphenazine—HTR7—coronary artery disease	0.000108	0.0257	CrCbGaD
Trifluoperazine—Asthenia—Perindopril—coronary artery disease	0.000107	0.000524	CcSEcCtD
Trifluoperazine—Dyspnoea—Ramipril—coronary artery disease	0.000107	0.000524	CcSEcCtD
Trifluoperazine—Hypersensitivity—Furosemide—coronary artery disease	0.000107	0.000523	CcSEcCtD
Trifluoperazine—Somnolence—Ramipril—coronary artery disease	0.000107	0.000523	CcSEcCtD
Trifluoperazine—Dizziness—Trandolapril—coronary artery disease	0.000107	0.000521	CcSEcCtD
Trifluoperazine—Insomnia—Timolol—coronary artery disease	0.000106	0.00052	CcSEcCtD
Trifluoperazine—Rash—Niacin—coronary artery disease	0.000106	0.00052	CcSEcCtD
Trifluoperazine—Dermatitis—Niacin—coronary artery disease	0.000106	0.000519	CcSEcCtD
Trifluoperazine—Dizziness—Enalapril—coronary artery disease	0.000106	0.000519	CcSEcCtD
Trifluoperazine—Skin disorder—Lisinopril—coronary artery disease	0.000106	0.000518	CcSEcCtD
Trifluoperazine—Pruritus—Perindopril—coronary artery disease	0.000106	0.000517	CcSEcCtD
Trifluoperazine—Headache—Niacin—coronary artery disease	0.000106	0.000516	CcSEcCtD
Trifluoperazine—Quetiapine—HTR7—coronary artery disease	0.000105	0.0252	CrCbGaD
Trifluoperazine—Dyspnoea—Timolol—coronary artery disease	0.000105	0.000512	CcSEcCtD
Trifluoperazine—Dizziness—Telmisartan—coronary artery disease	0.000105	0.000512	CcSEcCtD
Trifluoperazine—Rash—Pravastatin—coronary artery disease	0.000105	0.000512	CcSEcCtD
Trifluoperazine—Dermatitis—Pravastatin—coronary artery disease	0.000105	0.000511	CcSEcCtD
Trifluoperazine—Decreased appetite—Ramipril—coronary artery disease	0.000105	0.000511	CcSEcCtD
Trifluoperazine—Somnolence—Timolol—coronary artery disease	0.000105	0.000511	CcSEcCtD
Trifluoperazine—Asthenia—Furosemide—coronary artery disease	0.000104	0.00051	CcSEcCtD
Trifluoperazine—Headache—Pravastatin—coronary artery disease	0.000104	0.000508	CcSEcCtD
Trifluoperazine—Anorexia—Lisinopril—coronary artery disease	0.000104	0.000508	CcSEcCtD
Trifluoperazine—Fatigue—Ramipril—coronary artery disease	0.000104	0.000507	CcSEcCtD
Trifluoperazine—Hypersensitivity—Losartan—coronary artery disease	0.000103	0.000505	CcSEcCtD
Trifluoperazine—Nausea—Valsartan—coronary artery disease	0.000103	0.000503	CcSEcCtD
Trifluoperazine—Pruritus—Furosemide—coronary artery disease	0.000103	0.000503	CcSEcCtD
Trifluoperazine—Constipation—Ramipril—coronary artery disease	0.000103	0.000503	CcSEcCtD
Trifluoperazine—Nausea—Olmesartan—coronary artery disease	0.000103	0.000501	CcSEcCtD
Trifluoperazine—Decreased appetite—Timolol—coronary artery disease	0.000102	0.0005	CcSEcCtD
Trifluoperazine—Hypotension—Lisinopril—coronary artery disease	0.000102	0.000498	CcSEcCtD
Trifluoperazine—Dizziness—Captopril—coronary artery disease	0.000102	0.000498	CcSEcCtD
Trifluoperazine—Rash—Trandolapril—coronary artery disease	0.000102	0.000497	CcSEcCtD
Trifluoperazine—Dermatitis—Trandolapril—coronary artery disease	0.000102	0.000496	CcSEcCtD
Trifluoperazine—Fatigue—Timolol—coronary artery disease	0.000101	0.000495	CcSEcCtD
Trifluoperazine—Rash—Enalapril—coronary artery disease	0.000101	0.000495	CcSEcCtD
Trifluoperazine—Dermatitis—Enalapril—coronary artery disease	0.000101	0.000494	CcSEcCtD
Trifluoperazine—Headache—Trandolapril—coronary artery disease	0.000101	0.000494	CcSEcCtD
Trifluoperazine—Asthenia—Losartan—coronary artery disease	0.000101	0.000492	CcSEcCtD
Trifluoperazine—Headache—Enalapril—coronary artery disease	0.000101	0.000492	CcSEcCtD
Trifluoperazine—Nausea—Niacin—coronary artery disease	0.0001	0.00049	CcSEcCtD
Trifluoperazine—Rash—Telmisartan—coronary artery disease	9.99e-05	0.000488	CcSEcCtD
Trifluoperazine—Dermatitis—Telmisartan—coronary artery disease	9.98e-05	0.000488	CcSEcCtD
Trifluoperazine—Pruritus—Losartan—coronary artery disease	9.92e-05	0.000485	CcSEcCtD
Trifluoperazine—Headache—Telmisartan—coronary artery disease	9.92e-05	0.000485	CcSEcCtD
Trifluoperazine—Dizziness—Perindopril—coronary artery disease	9.89e-05	0.000483	CcSEcCtD
Trifluoperazine—Insomnia—Lisinopril—coronary artery disease	9.87e-05	0.000482	CcSEcCtD
Trifluoperazine—Nausea—Pravastatin—coronary artery disease	9.86e-05	0.000482	CcSEcCtD
Trifluoperazine—Pipotiazine—CYP2C19—coronary artery disease	9.76e-05	0.0233	CrCbGaD
Trifluoperazine—Dyspnoea—Lisinopril—coronary artery disease	9.73e-05	0.000475	CcSEcCtD
Trifluoperazine—Rash—Captopril—coronary artery disease	9.71e-05	0.000475	CcSEcCtD
Trifluoperazine—Dermatitis—Captopril—coronary artery disease	9.7e-05	0.000474	CcSEcCtD
Trifluoperazine—Somnolence—Lisinopril—coronary artery disease	9.7e-05	0.000474	CcSEcCtD
Trifluoperazine—Headache—Captopril—coronary artery disease	9.65e-05	0.000472	CcSEcCtD
Trifluoperazine—Dizziness—Furosemide—coronary artery disease	9.61e-05	0.00047	CcSEcCtD
Trifluoperazine—Nausea—Trandolapril—coronary artery disease	9.58e-05	0.000468	CcSEcCtD
Trifluoperazine—Urticaria—Ramipril—coronary artery disease	9.56e-05	0.000467	CcSEcCtD
Trifluoperazine—Nausea—Enalapril—coronary artery disease	9.54e-05	0.000466	CcSEcCtD
Trifluoperazine—Body temperature increased—Ramipril—coronary artery disease	9.51e-05	0.000465	CcSEcCtD
Trifluoperazine—Decreased appetite—Lisinopril—coronary artery disease	9.48e-05	0.000463	CcSEcCtD
Trifluoperazine—Rash—Perindopril—coronary artery disease	9.43e-05	0.000461	CcSEcCtD
Trifluoperazine—Dermatitis—Perindopril—coronary artery disease	9.42e-05	0.00046	CcSEcCtD
Trifluoperazine—Nausea—Telmisartan—coronary artery disease	9.41e-05	0.00046	CcSEcCtD
Trifluoperazine—Fatigue—Lisinopril—coronary artery disease	9.4e-05	0.00046	CcSEcCtD
Trifluoperazine—Headache—Perindopril—coronary artery disease	9.37e-05	0.000458	CcSEcCtD
Trifluoperazine—Urticaria—Timolol—coronary artery disease	9.34e-05	0.000457	CcSEcCtD
Trifluoperazine—Constipation—Lisinopril—coronary artery disease	9.33e-05	0.000456	CcSEcCtD
Trifluoperazine—Body temperature increased—Timolol—coronary artery disease	9.3e-05	0.000454	CcSEcCtD
Trifluoperazine—Dizziness—Losartan—coronary artery disease	9.28e-05	0.000453	CcSEcCtD
Trifluoperazine—Loxapine—ADRB1—coronary artery disease	9.25e-05	0.0221	CrCbGaD
Trifluoperazine—Zuclopenthixol—HTR2A—coronary artery disease	9.17e-05	0.0219	CrCbGaD
Trifluoperazine—Rash—Furosemide—coronary artery disease	9.17e-05	0.000448	CcSEcCtD
Trifluoperazine—Dermatitis—Furosemide—coronary artery disease	9.16e-05	0.000448	CcSEcCtD
Trifluoperazine—Nausea—Captopril—coronary artery disease	9.15e-05	0.000447	CcSEcCtD
Trifluoperazine—Nefazodone—HTR2A—coronary artery disease	9.12e-05	0.0218	CrCbGaD
Trifluoperazine—Headache—Furosemide—coronary artery disease	9.11e-05	0.000445	CcSEcCtD
Trifluoperazine—Clozapine—HTR7—coronary artery disease	9.07e-05	0.0216	CrCbGaD
Trifluoperazine—Nausea—Perindopril—coronary artery disease	8.88e-05	0.000434	CcSEcCtD
Trifluoperazine—Hypersensitivity—Ramipril—coronary artery disease	8.86e-05	0.000433	CcSEcCtD
Trifluoperazine—Rash—Losartan—coronary artery disease	8.84e-05	0.000432	CcSEcCtD
Trifluoperazine—Dermatitis—Losartan—coronary artery disease	8.84e-05	0.000432	CcSEcCtD
Trifluoperazine—Headache—Losartan—coronary artery disease	8.79e-05	0.000429	CcSEcCtD
Trifluoperazine—Urticaria—Lisinopril—coronary artery disease	8.67e-05	0.000423	CcSEcCtD
Trifluoperazine—Hypersensitivity—Timolol—coronary artery disease	8.66e-05	0.000423	CcSEcCtD
Trifluoperazine—Nausea—Furosemide—coronary artery disease	8.64e-05	0.000422	CcSEcCtD
Trifluoperazine—Asthenia—Ramipril—coronary artery disease	8.63e-05	0.000422	CcSEcCtD
Trifluoperazine—Body temperature increased—Lisinopril—coronary artery disease	8.62e-05	0.000421	CcSEcCtD
Trifluoperazine—Chlorpromazine—HTR7—coronary artery disease	8.53e-05	0.0204	CrCbGaD
Trifluoperazine—Pruritus—Ramipril—coronary artery disease	8.51e-05	0.000416	CcSEcCtD
Trifluoperazine—Trazodone—HTR2A—coronary artery disease	8.44e-05	0.0201	CrCbGaD
Trifluoperazine—Asthenia—Timolol—coronary artery disease	8.44e-05	0.000412	CcSEcCtD
Trifluoperazine—Nausea—Losartan—coronary artery disease	8.33e-05	0.000407	CcSEcCtD
Trifluoperazine—Pruritus—Timolol—coronary artery disease	8.32e-05	0.000407	CcSEcCtD
Trifluoperazine—Acepromazine—HTR2A—coronary artery disease	8.22e-05	0.0196	CrCbGaD
Trifluoperazine—Thioproperazine—HTR2A—coronary artery disease	8.04e-05	0.0192	CrCbGaD
Trifluoperazine—Hypersensitivity—Lisinopril—coronary artery disease	8.04e-05	0.000393	CcSEcCtD
Trifluoperazine—Dizziness—Ramipril—coronary artery disease	7.95e-05	0.000389	CcSEcCtD
Trifluoperazine—Pipotiazine—HTR2A—coronary artery disease	7.91e-05	0.0189	CrCbGaD
Trifluoperazine—Thiothixene—HTR2A—coronary artery disease	7.91e-05	0.0189	CrCbGaD
Trifluoperazine—Asthenia—Lisinopril—coronary artery disease	7.83e-05	0.000382	CcSEcCtD
Trifluoperazine—Mesoridazine—HTR2A—coronary artery disease	7.81e-05	0.0186	CrCbGaD
Trifluoperazine—Dizziness—Timolol—coronary artery disease	7.78e-05	0.00038	CcSEcCtD
Trifluoperazine—Pruritus—Lisinopril—coronary artery disease	7.72e-05	0.000377	CcSEcCtD
Trifluoperazine—Clomipramine—CYP2C19—coronary artery disease	7.71e-05	0.0184	CrCbGaD
Trifluoperazine—Rash—Ramipril—coronary artery disease	7.58e-05	0.000371	CcSEcCtD
Trifluoperazine—Dermatitis—Ramipril—coronary artery disease	7.58e-05	0.00037	CcSEcCtD
Trifluoperazine—Headache—Ramipril—coronary artery disease	7.53e-05	0.000368	CcSEcCtD
Trifluoperazine—Rash—Timolol—coronary artery disease	7.41e-05	0.000362	CcSEcCtD
Trifluoperazine—Dermatitis—Timolol—coronary artery disease	7.41e-05	0.000362	CcSEcCtD
Trifluoperazine—Headache—Timolol—coronary artery disease	7.37e-05	0.00036	CcSEcCtD
Trifluoperazine—Thioridazine—CYP2C19—coronary artery disease	7.26e-05	0.0173	CrCbGaD
Trifluoperazine—Dizziness—Lisinopril—coronary artery disease	7.21e-05	0.000353	CcSEcCtD
Trifluoperazine—Nausea—Ramipril—coronary artery disease	7.14e-05	0.000349	CcSEcCtD
Trifluoperazine—Nausea—Timolol—coronary artery disease	6.98e-05	0.000341	CcSEcCtD
Trifluoperazine—Rash—Lisinopril—coronary artery disease	6.88e-05	0.000336	CcSEcCtD
Trifluoperazine—Dermatitis—Lisinopril—coronary artery disease	6.87e-05	0.000336	CcSEcCtD
Trifluoperazine—Fluphenazine—HTR2A—coronary artery disease	6.84e-05	0.0163	CrCbGaD
Trifluoperazine—Headache—Lisinopril—coronary artery disease	6.83e-05	0.000334	CcSEcCtD
Trifluoperazine—Perphenazine—CYP2C19—coronary artery disease	6.67e-05	0.0159	CrCbGaD
Trifluoperazine—Propiomazine—HTR2A—coronary artery disease	6.58e-05	0.0157	CrCbGaD
Trifluoperazine—Quetiapine—CYP2C19—coronary artery disease	6.54e-05	0.0156	CrCbGaD
Trifluoperazine—Nausea—Lisinopril—coronary artery disease	6.48e-05	0.000317	CcSEcCtD
Trifluoperazine—Clomipramine—HTR2A—coronary artery disease	6.25e-05	0.0149	CrCbGaD
Trifluoperazine—Promazine—CYP2C19—coronary artery disease	6.01e-05	0.0143	CrCbGaD
Trifluoperazine—Thioridazine—HTR2A—coronary artery disease	5.89e-05	0.0141	CrCbGaD
Trifluoperazine—Acepromazine—ALB—coronary artery disease	5.63e-05	0.0134	CrCbGaD
Trifluoperazine—Clozapine—CYP2C19—coronary artery disease	5.62e-05	0.0134	CrCbGaD
Trifluoperazine—Methotrimeprazine—HTR2A—coronary artery disease	5.62e-05	0.0134	CrCbGaD
Trifluoperazine—Promethazine—HTR2A—coronary artery disease	5.54e-05	0.0132	CrCbGaD
Trifluoperazine—Thioproperazine—ALB—coronary artery disease	5.5e-05	0.0131	CrCbGaD
Trifluoperazine—Loxapine—HTR2A—coronary artery disease	5.43e-05	0.013	CrCbGaD
Trifluoperazine—Thiothixene—ALB—coronary artery disease	5.41e-05	0.0129	CrCbGaD
Trifluoperazine—Pipotiazine—ALB—coronary artery disease	5.41e-05	0.0129	CrCbGaD
Trifluoperazine—Perphenazine—HTR2A—coronary artery disease	5.4e-05	0.0129	CrCbGaD
Trifluoperazine—Quetiapine—HTR2A—coronary artery disease	5.3e-05	0.0127	CrCbGaD
Trifluoperazine—Promazine—HTR2A—coronary artery disease	4.87e-05	0.0116	CrCbGaD
Trifluoperazine—Clozapine—HTR2A—coronary artery disease	4.56e-05	0.0109	CrCbGaD
Trifluoperazine—Chlorpromazine—HTR2A—coronary artery disease	4.29e-05	0.0102	CrCbGaD
Trifluoperazine—Clomipramine—ALB—coronary artery disease	4.28e-05	0.0102	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—coronary artery disease	2.93e-05	0.007	CrCbGaD
Trifluoperazine—HRH1—Signaling Pathways—NOS3—coronary artery disease	1.53e-06	7.4e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	1.53e-06	7.38e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	1.52e-06	7.36e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—NOS3—coronary artery disease	1.52e-06	7.36e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—APOA1—coronary artery disease	1.52e-06	7.36e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.52e-06	7.35e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.52e-06	7.32e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.51e-06	7.31e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.51e-06	7.28e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	1.51e-06	7.28e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—AKT1—coronary artery disease	1.5e-06	7.26e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—AKT1—coronary artery disease	1.5e-06	7.26e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	1.5e-06	7.26e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.5e-06	7.25e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.5e-06	7.24e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.49e-06	7.22e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—AKT1—coronary artery disease	1.49e-06	7.21e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.49e-06	7.2e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.49e-06	7.2e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—JAK2—coronary artery disease	1.49e-06	7.19e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.49e-06	7.17e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KIT—coronary artery disease	1.48e-06	7.17e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KIT—coronary artery disease	1.48e-06	7.17e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—NOS3—coronary artery disease	1.47e-06	7.12e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—NOS3—coronary artery disease	1.47e-06	7.12e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—GSK3B—coronary artery disease	1.47e-06	7.11e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.47e-06	7.09e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—LPL—coronary artery disease	1.47e-06	7.09e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	1.46e-06	7.07e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.46e-06	7.06e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—POMC—coronary artery disease	1.46e-06	7.05e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CREB1—coronary artery disease	1.46e-06	7.05e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	1.46e-06	7.05e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.46e-06	7.05e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	1.46e-06	7.04e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—AKT1—coronary artery disease	1.44e-06	6.98e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—AKT1—coronary artery disease	1.44e-06	6.98e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.43e-06	6.93e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—GPX1—coronary artery disease	1.43e-06	6.92e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.43e-06	6.91e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCL2—coronary artery disease	1.43e-06	6.9e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.42e-06	6.88e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6R—coronary artery disease	1.42e-06	6.88e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—GSK3B—coronary artery disease	1.42e-06	6.88e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—GSK3B—coronary artery disease	1.42e-06	6.88e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.42e-06	6.85e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—POMC—coronary artery disease	1.41e-06	6.82e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—POMC—coronary artery disease	1.41e-06	6.82e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CREB1—coronary artery disease	1.41e-06	6.82e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CREB1—coronary artery disease	1.41e-06	6.82e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF1—coronary artery disease	1.4e-06	6.79e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—MAPK1—coronary artery disease	1.4e-06	6.75e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CD36—coronary artery disease	1.39e-06	6.73e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—coronary artery disease	1.39e-06	6.73e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.38e-06	6.68e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL2—coronary artery disease	1.38e-06	6.68e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL2—coronary artery disease	1.38e-06	6.68e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.38e-06	6.68e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6R—coronary artery disease	1.38e-06	6.66e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6R—coronary artery disease	1.38e-06	6.66e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.38e-06	6.65e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.37e-06	6.64e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.36e-06	6.57e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF1—coronary artery disease	1.36e-06	6.56e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF1—coronary artery disease	1.36e-06	6.56e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.36e-06	6.56e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—MAPK1—coronary artery disease	1.35e-06	6.53e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—MAPK1—coronary artery disease	1.35e-06	6.53e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	1.35e-06	6.52e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—coronary artery disease	1.35e-06	6.51e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—coronary artery disease	1.35e-06	6.51e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARG—coronary artery disease	1.34e-06	6.48e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	1.34e-06	6.45e-06	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.34e-06	6.45e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SERPINE1—coronary artery disease	1.33e-06	6.44e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	1.33e-06	6.44e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.32e-06	6.39e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—POMC—coronary artery disease	1.32e-06	6.39e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.32e-06	6.38e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.32e-06	6.35e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.31e-06	6.35e-06	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.31e-06	6.34e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.3e-06	6.29e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.3e-06	6.28e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.29e-06	6.25e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—FGF2—coronary artery disease	1.29e-06	6.24e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.29e-06	6.24e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.29e-06	6.24e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SERPINE1—coronary artery disease	1.29e-06	6.23e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SERPINE1—coronary artery disease	1.29e-06	6.23e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.29e-06	6.22e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	1.29e-06	6.22e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	1.28e-06	6.18e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.28e-06	6.18e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—MAPK1—coronary artery disease	1.28e-06	6.17e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	1.28e-06	6.16e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NOS3—coronary artery disease	1.27e-06	6.15e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1.27e-06	6.15e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.27e-06	6.14e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.27e-06	6.12e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	1.27e-06	6.12e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.27e-06	6.11e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AGT—coronary artery disease	1.26e-06	6.06e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.25e-06	6.04e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—FGF2—coronary artery disease	1.25e-06	6.03e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—FGF2—coronary artery disease	1.25e-06	6.03e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.24e-06	6.01e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	1.24e-06	6e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—JAK2—coronary artery disease	1.24e-06	5.98e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MAPK1—coronary artery disease	1.24e-06	5.97e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MAPK1—coronary artery disease	1.24e-06	5.97e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NOS3—coronary artery disease	1.23e-06	5.95e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NOS3—coronary artery disease	1.23e-06	5.95e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.23e-06	5.95e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOE—coronary artery disease	1.23e-06	5.94e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.23e-06	5.93e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—APOA1—coronary artery disease	1.22e-06	5.87e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.21e-06	5.86e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—PIK3CA—coronary artery disease	1.21e-06	5.86e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.21e-06	5.84e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ALB—coronary artery disease	1.21e-06	5.83e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	1.21e-06	5.82e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—coronary artery disease	1.2e-06	5.81e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JAK2—coronary artery disease	1.2e-06	5.78e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JAK2—coronary artery disease	1.2e-06	5.78e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—coronary artery disease	1.2e-06	5.77e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.19e-06	5.77e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.19e-06	5.75e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MAPK1—coronary artery disease	1.18e-06	5.7e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	1.17e-06	5.67e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.17e-06	5.67e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.17e-06	5.67e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.17e-06	5.66e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	1.17e-06	5.65e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.17e-06	5.64e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.16e-06	5.62e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—coronary artery disease	1.16e-06	5.62e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—coronary artery disease	1.16e-06	5.62e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—coronary artery disease	1.15e-06	5.58e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	1.15e-06	5.56e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1.15e-06	5.53e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MAPK1—coronary artery disease	1.14e-06	5.51e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MAPK1—coronary artery disease	1.14e-06	5.51e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CXCL8—coronary artery disease	1.13e-06	5.46e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	1.12e-06	5.43e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—PIK3CA—coronary artery disease	1.11e-06	5.35e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.11e-06	5.34e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.1e-06	5.33e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—coronary artery disease	1.1e-06	5.33e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CXCL8—coronary artery disease	1.09e-06	5.28e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CXCL8—coronary artery disease	1.09e-06	5.28e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.09e-06	5.24e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	1.08e-06	5.23e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—coronary artery disease	1.08e-06	5.22e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—coronary artery disease	1.07e-06	5.19e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—PIK3CA—coronary artery disease	1.07e-06	5.18e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—PIK3CA—coronary artery disease	1.07e-06	5.18e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—coronary artery disease	1.07e-06	5.18e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—POMC—coronary artery disease	1.06e-06	5.1e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—coronary artery disease	1.06e-06	5.1e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCND1—coronary artery disease	1.05e-06	5.08e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—coronary artery disease	1.05e-06	5.05e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—coronary artery disease	1.05e-06	5.05e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—coronary artery disease	1.04e-06	5.02e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—coronary artery disease	1.04e-06	5.02e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	1.03e-06	4.98e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PIK3CA—coronary artery disease	1.02e-06	4.94e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—coronary artery disease	1.02e-06	4.94e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCND1—coronary artery disease	1.02e-06	4.92e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCND1—coronary artery disease	1.02e-06	4.92e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.01e-06	4.9e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.01e-06	4.89e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.01e-06	4.88e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	9.99e-07	4.83e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	9.96e-07	4.81e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	9.95e-07	4.81e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	9.94e-07	4.8e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	9.93e-07	4.8e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	9.93e-07	4.8e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—coronary artery disease	9.91e-07	4.79e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PIK3CA—coronary artery disease	9.9e-07	4.78e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PIK3CA—coronary artery disease	9.9e-07	4.78e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—coronary artery disease	9.88e-07	4.77e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—coronary artery disease	9.88e-07	4.77e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—coronary artery disease	9.82e-07	4.74e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	9.77e-07	4.72e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	9.74e-07	4.71e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—coronary artery disease	9.63e-07	4.65e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—coronary artery disease	9.59e-07	4.63e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—coronary artery disease	9.59e-07	4.63e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—coronary artery disease	9.49e-07	4.59e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—coronary artery disease	9.49e-07	4.59e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—coronary artery disease	9.21e-07	4.45e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—coronary artery disease	9.18e-07	4.43e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—coronary artery disease	9.06e-07	4.38e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—coronary artery disease	9.06e-07	4.37e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—coronary artery disease	8.88e-07	4.29e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—coronary artery disease	8.88e-07	4.29e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—coronary artery disease	8.85e-07	4.27e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—coronary artery disease	8.8e-07	4.25e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	8.77e-07	4.24e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—coronary artery disease	8.77e-07	4.23e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—coronary artery disease	8.77e-07	4.23e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—coronary artery disease	8.76e-07	4.23e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—coronary artery disease	8.76e-07	4.23e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	8.63e-07	4.17e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	8.61e-07	4.16e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CA—coronary artery disease	8.57e-07	4.14e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	8.48e-07	4.09e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	8.45e-07	4.08e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—coronary artery disease	8.43e-07	4.07e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—coronary artery disease	8.42e-07	4.07e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—coronary artery disease	8.36e-07	4.04e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CA—coronary artery disease	8.29e-07	4e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CA—coronary artery disease	8.29e-07	4e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK1—coronary artery disease	8.26e-07	3.99e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	8.16e-07	3.94e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—coronary artery disease	8.15e-07	3.94e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—coronary artery disease	8.15e-07	3.94e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	8.12e-07	3.92e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—coronary artery disease	8.09e-07	3.91e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—coronary artery disease	8.09e-07	3.91e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK1—coronary artery disease	7.99e-07	3.86e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK1—coronary artery disease	7.99e-07	3.86e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—coronary artery disease	7.77e-07	3.75e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—coronary artery disease	7.64e-07	3.69e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—coronary artery disease	7.63e-07	3.68e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—coronary artery disease	7.51e-07	3.63e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	7.49e-07	3.62e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—coronary artery disease	7.17e-07	3.46e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CA—coronary artery disease	7.17e-07	3.46e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	7.05e-07	3.41e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—coronary artery disease	7.04e-07	3.4e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—coronary artery disease	7e-07	3.38e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CA—coronary artery disease	6.93e-07	3.35e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CA—coronary artery disease	6.93e-07	3.35e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	6.92e-07	3.34e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	6.91e-07	3.34e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—coronary artery disease	6.77e-07	3.27e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—coronary artery disease	6.77e-07	3.27e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CA—coronary artery disease	6.5e-07	3.14e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—coronary artery disease	6.35e-07	3.07e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—coronary artery disease	6.14e-07	2.97e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—coronary artery disease	6.14e-07	2.97e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—coronary artery disease	5.85e-07	2.83e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—coronary artery disease	5.66e-07	2.74e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—coronary artery disease	5.66e-07	2.74e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—coronary artery disease	5.31e-07	2.56e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	5.19e-07	2.5e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—coronary artery disease	4.24e-07	2.05e-06	CbGpPWpGaD
